We are international
• about imf TEXT SIZE   
International Myeloma Working Group

The International Myeloma Working Group, a collaborative group of leading myeloma specialists around the globe, has a two-fold task: to publish consensus statements and guidelines for the management of myeloma and to conduct translational research—from lab bench to patient bedside--under the auspices of the International Myeloma Foundation. The following publications represent the work of the International Myeloma Working Group.

Combining Fluorescent In Situ Hybridization (iFISH) data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group (IMWG) collaborative project
Avet-Loiseau H, Morgan G, et al.
Leukemia. 2013 Mar;27(3):711-7.
Confirmation of the utility of the International Staging System and identification of a unique pattern of disease in Brazilian patients with multiple myeloma
Hungria, V, Maiolino A, et al.
Haematologica.2008 May;93(5):791-2

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders
The International Myeloma Working Group. British Journal of Haematology. 2003 Jun; 121(5):749–57.
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping
Johnson DC, Corthals S., et. al
Blood 2008 Dec 15;112(13):4924-34

Geriatric assessment predicts survival and toxicities in elderly myeloma: an International Myeloma Working Group report
Palumbo A., Bringhen S., et al.
Blood Jan 2015;10.1182/blood-2014-12-615187
International myeloma working group guidelines for serum free light chain analysis in multiple myeloma and related disorders
Dispenzieri A, Kyle R, Merlini G, et al.
Leukemia. 2009 Feb;23(2):215-24.

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
Rajkumar S., Dimopoulos M., et al.
Lancet Oncol 2014;15:e538-48
International Staging System for Multiple Myeloma
Greipp P, San Miguel J, et al. Journal of Clinical Oncology. 2005 Apr; 20(5):1-9.

International uniform response criteria for multiple myeloma
Durie B, Harousseau J, et al. Leukemia.
2006 Jul;20(10):1–7.
Molecular Classification of Multiple Myeloma
Spotlight Review
Fonseca R, Bergsagel P, et al. Leukemia.
2009 Dec; 23(12): 2210-21.

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.
Kyle RA, Boccadoro M, Rajkumar SV, Durie BGM.
Leukemia. 2010 Jun;24(6):1121-7.
Myeloma Management Guidelines
Durie BG, Kyle R, et al. The Hematology Journal.
2003 Apr; 4(6):379-98.

Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations
Fernandez de Larrea C, Shah J, et al.
Leukemia. 2013 Apr; 27(4):780-91.
Risk Stratification in Multiple Myeloma
Chng WJ, Avet Loiseau H et al.
Leukemia 2014 Feb; 28(2):269-277

Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement
Dimopoulos MA, Hillengass J, ET AL.
J of Clin Oncol. 2015 Jan 20
Serum free light chain analysis in multiple myeloma and related disorders
Spotlight Review
Dispenzieri A, Kyle R, et al. Leukemia.
2009 Feb; 23(2):215-24.

The Current Role of Imaging Techniques in the Diagnosis and Monitoring of Multiple Myeloma
Dimopoulos M, Terpos E, et al. Leukemia.
2009 Sep; 23(9):1545-56.